Correlation Between Sprint Bioscience and Enorama Pharma
Can any of the company-specific risk be diversified away by investing in both Sprint Bioscience and Enorama Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprint Bioscience and Enorama Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprint Bioscience AB and Enorama Pharma AB, you can compare the effects of market volatilities on Sprint Bioscience and Enorama Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprint Bioscience with a short position of Enorama Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprint Bioscience and Enorama Pharma.
Diversification Opportunities for Sprint Bioscience and Enorama Pharma
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Sprint and Enorama is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Sprint Bioscience AB and Enorama Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enorama Pharma AB and Sprint Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprint Bioscience AB are associated (or correlated) with Enorama Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enorama Pharma AB has no effect on the direction of Sprint Bioscience i.e., Sprint Bioscience and Enorama Pharma go up and down completely randomly.
Pair Corralation between Sprint Bioscience and Enorama Pharma
Assuming the 90 days trading horizon Sprint Bioscience AB is expected to generate 1.6 times more return on investment than Enorama Pharma. However, Sprint Bioscience is 1.6 times more volatile than Enorama Pharma AB. It trades about 0.05 of its potential returns per unit of risk. Enorama Pharma AB is currently generating about 0.04 per unit of risk. If you would invest 68.00 in Sprint Bioscience AB on August 29, 2024 and sell it today you would earn a total of 107.00 from holding Sprint Bioscience AB or generate 157.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sprint Bioscience AB vs. Enorama Pharma AB
Performance |
| Timeline |
| Sprint Bioscience |
| Enorama Pharma AB |
Sprint Bioscience and Enorama Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sprint Bioscience and Enorama Pharma
The main advantage of trading using opposite Sprint Bioscience and Enorama Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprint Bioscience position performs unexpectedly, Enorama Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enorama Pharma will offset losses from the drop in Enorama Pharma's long position.| Sprint Bioscience vs. Cantargia AB | Sprint Bioscience vs. Saniona AB | Sprint Bioscience vs. Acarix AS | Sprint Bioscience vs. Gabather AB |
| Enorama Pharma vs. Cantargia AB | Enorama Pharma vs. Enzymatica publ AB | Enorama Pharma vs. Lidds AB | Enorama Pharma vs. BioArctic AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |